Novo Nordisk A/S

NVO

New York Stock Exchange. Currency in USD

126.13 +1.53 ( +1.23% )

Real time prices: December 01

Market Cap.
284.01B
Beta (5Y monthly)
0.32
Price/Earnings
13.31
EPS (TTM)
8.85
Forward Dividend
1.60 (1.32%)
Ex-Dividend Date
Aug 15, 2022
Volume
988,261
1y Target Est.
126.14
Day's Range
125.16
-
126.41
52 Week's Range
91.51
-
126.41

Historical Summary

Performance
EPS growth
Share Buybacks

About Novo Nordisk A/S

Sector
Healthcare
Industry
Biotechnology
Website
https://www.novonordisk.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
2.27B
Employees
52696
Address
Novo Allé 1, Bagsvaerd, Denmark, 2880
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Latest news

3 Healthcare Stocks That Could Set You Up For Life
3 Healthcare Stocks That Could Set You Up For Life

All offer products that are invaluable to their respective audiences.
By The Motley Fool - 1 week ago

Prothena (PRTA) Earns Milestone Payment From Novo Nordisk
Prothena (PRTA) Earns Milestone Payment From Novo Nordisk

Prothena (PRTA) earns a $40 million milestone payment from Novo Nordisk following the progress of...
By Zacks Investment Research - 1 week ago

The Zacks Analyst Blog Highlights Novo Nordisk, Amgen, Automatic Data Processing, Equinor and Illinois Tool Works
The Zacks Analyst Blog Highlights Novo Nordisk, Amgen, Automatic Data Processing, Equinor and Illinois Tool Works

Novo Nordisk, Amgen, Automatic Data Processing, Equinor and Illinois Tool Works are included in this...
By Zacks Investment Research - 2 weeks ago

Top Research Reports for Novo Nordisk, Amgen & ADP
Top Research Reports for Novo Nordisk, Amgen & ADP

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S...
By Zacks Investment Research - 2 weeks ago

BAYRY vs. NVO: Which Stock Is the Better Value Option?
BAYRY vs. NVO: Which Stock Is the Better Value Option?

BAYRY vs. NVO: Which Stock Is the Better Value Option?
By Zacks Investment Research - 2 weeks ago

Novo Releases Inaugural Sustainability Statement
Novo Releases Inaugural Sustainability Statement

VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the...
By GlobeNewswire Inc. - 2 weeks ago

Beat the Market Like Zacks: JPMorgan, Berkshire Hathaway, Amgen in Focus
Beat the Market Like Zacks: JPMorgan, Berkshire Hathaway, Amgen in Focus

Our time-tested methodologies were at work to help investors navigate the market well last week....
By Zacks Investment Research - 2 weeks ago

Why Teva Stock Stumbled Again on Friday
Why Teva Stock Stumbled Again on Friday

A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments.
By The Motley Fool - 3 weeks ago